1.64
price up icon0.00%   0.00
after-market Handel nachbörslich: 1.62 -0.02 -1.22%
loading
Schlusskurs vom Vortag:
$1.64
Offen:
$1.65
24-Stunden-Volumen:
111.38K
Relative Volume:
0.52
Marktkapitalisierung:
$157.58M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-18.75M
KGV:
-4.10
EPS:
-0.4
Netto-Cashflow:
$-62.91M
1W Leistung:
-1.80%
1M Leistung:
-10.38%
6M Leistung:
-22.27%
1J Leistung:
+120.96%
1-Tages-Spanne:
Value
$1.63
$1.67
1-Wochen-Bereich:
Value
$1.59
$1.72
52-Wochen-Spanne:
Value
$0.53
$3.0301

Compugen Ltd Stock (CGEN) Company Profile

Name
Firmenname
Compugen Ltd
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
0
Name
Twitter
@CompugenLtd
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
CGEN's Discussions on Twitter

Compugen Ltd Stock (CGEN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-08-05 Herabstufung Jefferies Buy → Hold
2020-05-26 Fortgesetzt JMP Securities Mkt Outperform
2020-05-13 Eingeleitet Stifel Buy
2020-05-07 Eingeleitet SVB Leerink Outperform
2020-04-22 Eingeleitet ROTH Capital Buy
2020-03-24 Eingeleitet SunTrust Buy
2020-01-16 Eingeleitet Cantor Fitzgerald Overweight
2018-03-29 Eingeleitet Oppenheimer Outperform
2016-02-01 Fortgesetzt Oppenheimer Outperform
2015-10-15 Eingeleitet FBR Capital Outperform
2015-04-23 Fortgesetzt Jefferies Buy
2015-04-21 Eingeleitet Oppenheimer Outperform
2014-02-07 Eingeleitet MLV & Co Buy
2009-12-28 Bestätigt Cantor Fitzgerald Buy
2009-07-29 Eingeleitet Cantor Fitzgerald Buy
Alle ansehen

Compugen Ltd Aktie (CGEN) Neueste Nachrichten

pulisher
01:37 AM

Compugen (CGEN) to Release Earnings on Tuesday - MarketBeat

01:37 AM
pulisher
09:31 AM

Compugen Showcases Promising Data on Ovarian Cancer Therapy - TipRanks

09:31 AM
pulisher
Oct 29, 2024

Short Interest in Compugen Ltd. (NASDAQ:CGEN) Decreases By 17.1% - MarketBeat

Oct 29, 2024
pulisher
Oct 29, 2024

Compugen to Release Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - cnhinews.com

Oct 29, 2024
pulisher
Oct 24, 2024

Compugen Gears Up to Report Q3 Earnings: Here's What to Expect - Yahoo Finance

Oct 24, 2024
pulisher
Oct 07, 2024

Compugen to Present New Clinical Data at SITC 2024 - StockTitan

Oct 07, 2024
pulisher
Oct 03, 2024

Compugen Ltd. (NASDAQ:CGEN) Shares Sold by Renaissance Technologies LLC - Defense World

Oct 03, 2024
pulisher
Sep 30, 2024

Compugen’s stock rockets on deal with Gilead for anti-tumor drug - MSN

Sep 30, 2024
pulisher
Sep 29, 2024

Compugen Ltd. (NASDAQ:CGEN) Sees Large Growth in Short Interest - Defense World

Sep 29, 2024
pulisher
Sep 28, 2024

CompoSecure Inc (CMPO) Analyst Thoughts: How High Can It Go? - Stocks Register

Sep 28, 2024
pulisher
Sep 19, 2024

Compugen Ltd. (NASDAQ:CGEN) Short Interest Update - Defense World

Sep 19, 2024
pulisher
Sep 13, 2024

Compugen Shareholders Approve All Proposals - TipRanks

Sep 13, 2024
pulisher
Sep 11, 2024

Compugen (CGEN) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance

Sep 11, 2024
pulisher
Sep 09, 2024

Compugen to Present at Single Cell Genomics 2024 Conference - StockTitan

Sep 09, 2024
pulisher
Sep 06, 2024

Compugen Ltd (CGEN)’s Market Momentum: Closing Strong at 1.82, Down -7.61 - The Dwinnex

Sep 06, 2024
pulisher
Sep 06, 2024

Compugen Ltd’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle

Sep 06, 2024
pulisher
Sep 04, 2024

Compugen Ltd (CGEN) shows promising results - US Post News

Sep 04, 2024
pulisher
Sep 02, 2024

Rothschild Investment LLC Buys Shares of 221,900 Compugen Ltd. (NASDAQ:CGEN) - Defense World

Sep 02, 2024
pulisher
Aug 29, 2024

CGENCompugen Ltd Latest Stock News & Market Updates - StockTitan

Aug 29, 2024
pulisher
Aug 29, 2024

Compugen to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Aug 29, 2024
pulisher
Aug 26, 2024

Can Compugen (CGEN) Run Higher on Rising Earnings Estimates? - Yahoo Finance

Aug 26, 2024
pulisher
Aug 22, 2024

Investors Aren't Buying Compugen Ltd.'s (NASDAQ:CGEN) Revenues - Simply Wall St

Aug 22, 2024
pulisher
Aug 15, 2024

Compugen (NASDAQ:CGEN) Lifted to “Buy” at StockNews.com - Defense World

Aug 15, 2024
pulisher
Aug 15, 2024

Compugen (NASDAQ:CGEN) Lifted to Buy at StockNews.com - MarketBeat

Aug 15, 2024
pulisher
Aug 11, 2024

Party Time: Brokers Just Made Major Increases To Their Compugen Ltd. (NASDAQ:CGEN) Earnings Forecasts - Yahoo Finance

Aug 11, 2024
pulisher
Aug 10, 2024

Compugen Ltd. (CGEN) Q2 2024 Earnings Call Transcript - Seeking Alpha

Aug 10, 2024
pulisher
Aug 08, 2024

Compugen (NASDAQ:CGEN) Downgraded by StockNews.com to Hold - Defense World

Aug 08, 2024
pulisher
Aug 07, 2024

Compugen Ltd. (NASDAQ:CGEN): When Will It Breakeven? - Yahoo Finance

Aug 07, 2024
pulisher
Aug 07, 2024

Compugen: Q2 Earnings Snapshot - San Antonio Express-News

Aug 07, 2024
pulisher
Aug 06, 2024

Compugen Ltd reports results for the quarter ended in JanuaryEarnings Summary - TradingView

Aug 06, 2024
pulisher
Aug 06, 2024

Compugen (CGEN) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Aug 06, 2024
pulisher
Aug 06, 2024

Compugen’s Strategic Milestones Boost Q2 2024 Outlook - TipRanks

Aug 06, 2024
pulisher
Aug 06, 2024

Compugen earnings beat by $0.07, revenue topped estimates - Investing.com Australia

Aug 06, 2024
pulisher
Aug 06, 2024

Compugen Reports Second Quarter 2024 Results - StockTitan

Aug 06, 2024
pulisher
Aug 06, 2024

Compugen reports Q2 EPS (2c), consensus (7c) - TipRanks

Aug 06, 2024
pulisher
Aug 05, 2024

Compugen Ltd. Calls for 2024 Shareholder Meeting - TipRanks

Aug 05, 2024
pulisher
Aug 04, 2024

Compugen (CGEN) to Release Quarterly Earnings on Tuesday - Defense World

Aug 04, 2024
pulisher
Aug 02, 2024

How to interpret Compugen Ltd (CGEN)’s stock chart patterns - US Post News

Aug 02, 2024
pulisher
Jul 30, 2024

Compugen (CGEN) Set to Announce Earnings on Tuesday - MarketBeat

Jul 30, 2024
pulisher
Jul 30, 2024

Compugen receives FDA approval for Phase I trial of solid tumour treatment - Clinical Trials Arena

Jul 30, 2024
pulisher
Jul 29, 2024

Compugen’s COM503 Advances with FDA Nod and Gilead Deal - TipRanks

Jul 29, 2024
pulisher
Jul 29, 2024

Compugen Announces FDA Clearance of IND for COM503 for the Treatment of Solid Tumors - Lelezard

Jul 29, 2024
pulisher
Jul 23, 2024

Compugen to Release Second Quarter 2024 Results on Tuesday, August 6, 2024 - StockTitan

Jul 23, 2024
pulisher
Jul 18, 2024

Alterity Up on Interim Data From Advance MSA Study - Markets Insider

Jul 18, 2024
pulisher
Jul 16, 2024

CGEN’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

Jul 16, 2024
pulisher
Jul 15, 2024

Computational Biology Market will generate new growth - openPR

Jul 15, 2024
pulisher
Jul 04, 2024

Computational Biology Market Growth Drivers | Computing Group Inc., Simulation Plus Inc., Compugen Ltd. – Economica - Economica

Jul 04, 2024
pulisher
Jul 02, 2024

Longboard (LBPH) Up 14% as Epilepsy Drug Gets Breakthrough Tag - Zacks Investment Research

Jul 02, 2024
pulisher
Jul 02, 2024

The past three years for Compugen (NASDAQ:CGEN) investors has not been profitable - Yahoo Finance

Jul 02, 2024

Finanzdaten der Compugen Ltd-Aktie (CGEN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):